DECA-DURABOLIN sol inj 50 mg i.m. amp 1 ml
7680266600683
CH-26660
A14AB01
07.08.5.
Reimbursement limitations:
DECADURABOL2
Prise en charge exclusivement pour le traitement de l’ostéoporose postménopausique sévère, lorsque d’autres options thérapeutiques …
1 / 3
google
Details
- Product number
- 2666003
- CPT
- -
- Packaging group
- 1 x 1 ml
- Unit
- Ampulle(n)
- Composition
- nandroloni decanoas 50 mg, alcohol benzylicus 0.1 ml, arachidis oleum, q.s. ad suspensionem pro 1 ml.
Articles (1)
Deca-Durabolin 50 mg, Injektionslösung (i.m.)
Injektionslösung
1 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.1 ML | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 17.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1962
Authorization holder
Aspen Pharma Schweiz GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 26660
- Drug name
- Deca-Durabolin, Injektionslösung (i.m.)
- Galenic form
- LSINJ
- ATC Code
- A14AB01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/10/1960
- Authorization expiration date
- 31/12/9999
- IT number
- 07.08.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DECA-DURABOLIN sol inj 50 mg i.m. amp 1 ml
- Description (DE)
- DECA-DURABOLIN Inj Lös 50 mg i.m. Amp 1 ml
- Market launch
- 05/10/1960
- Narcotic (BTM)
- No